TrialNature medicine2024
Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial.
Xiangyu Gao et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
43 papers cite it
this paperpooled ittrialcites it